Enovis Long Term Debt 2010-2024 | ENOV

Enovis long term debt from 2010 to 2024. Long term debt can be defined as the sum of all long term debt fields.
Enovis Annual Long Term Debt
(Millions of US $)
2023 $466
2022 $40
2021 $2,079
2020 $2,204
2019 $2,284
2018 $1,192
2017 $1,055
2016 $1,287
2015 $1,412
2014 $1,527
2013 $1,458
2012 $1,694
2011 $102
2010 $73
2009 $83
Enovis Quarterly Long Term Debt
(Millions of US $)
2024-09-30 $1,325
2024-06-30 $1,329
2024-03-31 $1,318
2023-12-31 $466
2023-09-30 $395
2023-06-30 $400
2023-03-31 $285
2022-12-31 $40
2022-09-30
2022-06-30
2022-03-31 $1,648
2021-12-31 $2,079
2021-09-30 $1,612
2021-06-30 $1,577
2021-03-31 $1,482
2020-12-31 $2,204
2020-09-30 $2,192
2020-06-30 $2,221
2020-03-31 $2,513
2019-12-31 $2,284
2019-09-30 $4,002
2019-06-30 $4,078
2019-03-31 $4,037
2018-12-31 $1,192
2018-09-30 $1,136
2018-06-30 $1,067
2018-03-31 $1,122
2017-12-31 $1,055
2017-09-30 $1,335
2017-06-30 $1,322
2017-03-31 $1,245
2016-12-31 $1,287
2016-09-30 $1,379
2016-06-30 $1,400
2016-03-31 $1,440
2015-12-31 $1,412
2015-09-30 $1,532
2015-06-30 $1,377
2015-03-31 $1,428
2014-12-31 $1,527
2014-09-30 $1,608
2014-06-30 $1,812
2014-03-31 $1,108
2013-12-31 $1,458
2013-09-30 $1,389
2013-06-30 $1,411
2013-03-31 $1,446
2012-12-31 $1,694
2012-09-30 $1,659
2012-06-30 $1,658
2012-03-31 $1,696
2011-12-31 $102
2011-09-30 $65
2011-06-30 $71
2011-03-31 $74
2010-12-31 $73
2010-09-30 $75
2010-06-30 $78
2010-03-31 $80
2009-12-31 $83
2009-09-30 $85
2009-06-30 $88
2009-03-31 $90
Sector Industry Market Cap Revenue
Medical Medical Information Systems $2.475B $1.707B
Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE.
Stock Name Country Market Cap PE Ratio
Inspire Medical Systems (INSP) United States $5.669B 176.81
Hims & Hers Health (HIMS) United States $5.506B 140.00
Tempus AI (TEM) United States $5.393B 0.00
IRhythm Technologies (IRTC) United States $2.799B 0.00
Privia Health (PRVA) United States $2.357B 196.40
Azenta (AZTA) United States $2.286B 122.05
Omnicell (OMCL) United States $2.053B 67.15
10x Genomics (TXG) United States $1.718B 0.00
Clover Health Investments (CLOV) United States $1.568B 0.00
Schrodinger (SDGR) United States $1.486B 0.00
Phreesia (PHR) United States $1.464B 0.00
Butterfly Network (BFLY) United States $0.846B 0.00
Standard BioTools (LAB) United States $0.651B 0.00
Fulgent Genetics (FLGT) United States $0.563B 0.00
Talkspace (TALK) United States $0.529B 0.00
Definitive Healthcare (DH) United States $0.476B 82.40
Health Catalyst (HCAT) United States $0.446B 0.00
TruBridge (TBRG) United States $0.297B 86.52
Pulmonx (LUNG) United States $0.257B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.209B 0.00
EUDA Health Holdings (EUDA) Singapore $0.114B 0.00
American Well (AMWL) United States $0.108B 0.00
P3 Health Partners (PIII) United States $0.090B 0.00
HeartBeam (BEAT) United States $0.063B 0.00
CareCloud (CCLD) United States $0.062B 0.00
Outset Medical (OM) United States $0.061B 0.00
111 (YI) China $0.054B 0.00
Zepp Health (ZEPP) China $0.043B 0.00
Zhongchao (ZCMD) China $0.043B 0.00
SHL Telemedicine (SHLT) Israel $0.041B 0.00
Movano (MOVE) United States $0.035B 0.00
Bullfrog AI Holdings (BFRG) United States $0.018B 0.00
MSP Recovery (MSPR) United States $0.016B 0.00
Streamline Health Solutions (STRM) United States $0.016B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.014B 0.00
Strata Skin Sciences (SSKN) United States $0.012B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.008B 0.00
Precipio (PRPO) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.005B 0.00
Syra Health (SYRA) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00